To assess the effects of discontinuation compared with continued use of anticholinergic drugs prescribed for antipsychotic-induced extrapyramidal symptoms in people with schizophrenia and related disorders including schizophreniform disorder, delusional disorder, psychosis and schizoaffective disorder.